Fig. 2

The clinical predictor SNORA68 is associated with TNBC. A Schematic diagram of SNORA68 as a clinical predictor of TNBC. B qRT-PCR was used to detect the expression of SNORA68 in TNBC tissues and normal tissues adjacent to tumors. C qRT-PCR was used to detect the expression of plasma SNORA68 in patients who reached CB or did not reach CB. D The expression of SNORA68 in primary biopsy samples was positively related to plasma SNORA68 expression. E Range of SNORA68 ISH in biopsy samples. F The expression of SNORA68 in breast cancer tissues was detected by ISH. G, H DFS and OS were compared between the SNORA68 high-expression group and the SNORA68 low-expression group. * P < 0.05, ** P < 0.01